Placeholder

Supply Chain Strategies

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 1887. Categories: , , .

Product Description

As with all other areas, globalization will have a tremendous impact on the pharmaceutical supply chain. The industry will have to manage resources that are much more widely dispersed.

Globalization and multichannel distribution systems — coupled with the concern about counterfeiting and making distribution more efficient — are creating a more complex supply chain.
Mark Hassenplug, global life-sciences supply chain leader at Ernst & Young, says supply chains are now traversing multiple geographic regions with numerous import and export rules, regulations, customs, and duties, with fines and penalties increasing for noncompliance.
“With new global players entering the value chain, there can be increased vulnerability to counterfeiting and safety lapses, with important implications for patient health and a company’s reputation,” he says. “Ultimately, lapses in this area can also lead to increased scrutiny…

Digital Exclusive Supply Chain Best Practices
Access Demo Commercial Operations Outsourcing: A Leading-edge Response to the Financial Storm Affecting the Life-sciences Industry
Access Demo Developing Global Supply Chain Best Practices for Clinical Trials

Sidebar:
Supply Chain a Top Concern
Sound Bites From the Field

Bob Celeste is Director, GS1 Healthcare US
Bill Hook is VP of Global Strategy, Healthcare ­Logistics, UPS Supply Chain Solutions
Terry Hisey is Vice ­Chairman and U.S. Industry Leader, Deloitte LLP’s Life Sciences Practice
Tom Russell is General Manager of ­Enterprise Solutions, SciQuest Inc.
Te Smith is VP of ­Communications at ­MarkMonitor,

Experts on this topic
John Chiminski. President and CEO, Catalent Pharma Solutions, a provider of advanced dose form and ­packaging ­technologies, development ­manufacturing, and packaging services to the global ­pharmaceutical and biotech industry. For more information, visit ­catalent.com.
Robert Finamore. Director of ­Validation Services, QPharma, which ­delivers a suite of compliance services, that span the product development life cycle, from quality and validation solutions to PDMA and fulfillment services. For more ­information, visit qpharmacorp.com.
Astrid Frank. General Manager, Fisher ­Clinical Services, Basel, Switzerland, facility, which offers services to support the ­continuum of supply chain needs within a ­clinical trial setting. For more information, visit fisherclinicalservices.com.
Mark B. Hassenplug. Global Life Sciences Supply Chain Leader, Ernst & Young, a provider of assurance, tax, transaction, and ­advisory services. For more information, visit ey.com.
Bill Hook. VP of Global Strategy, Healthcare ­Logistics, UPS Supply Chain Solutions, a package ­delivery company and a global provider of supply chain services. For more information, visit ups-scs.com.
Ellen E. Reilly. Managing Director, Pharmaceutical and Life Sciences Advisory Services Group, ­PricewaterhouseCoopers, which provides industry-focused assurance, tax, and advisory services. For more information, visit pwc.com.
Bob Silvers. Managing Director, SSA & Co., a global operations consulting firm. For more information, visit ssaandco.com.

FEEDBACK